Press release
Von Hippel-Lindau Disease Treatment Market Size 2034 | Roche, Exelixis, Bayer, Novartis, and others.
Von Hippel-Lindau Disease Treatment Market
Explore the intricate details of the Von Hippel-Lindau (VHL) Disease Market: Uncover drug uptake, treatment dynamics, and epidemiological trends with our comprehensive Von Hippel-Lindau (VHL) Disease Market Forecast. Click here to stay ahead in healthcare innovation @ Von Hippel-Lindau Disease Market Size- https://www.delveinsight.com/sample-request/von-hippel-lindau-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Von Hippel-Lindau (VHL) Disease Market Report
• June 2024:- Merck Sharp & Dohme LLC- A Phase 2 Study to Evaluate the Efficacy and Safety of Belzutifan (MK-6482, Formerly PT2977) Monotherapy in Participants With Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Advanced Solid Tumors With HIF-2α Related Genetic Alterations.
• Among the 7MM, the United States accounted for the highest number of total prevalent cases of Von Hippel-Lindau disease, i.e. ~9,500 in 2023.
• In EU4 and the UK, Germany accounted for the highest number of total Diagnosed cases of Von Hippel-Lindau disease, whereas Spain accounts for the lowest, in 2023.
• In 2023, in the US, the most prevalent clinical manifestation-specific cases of Von Hippel-Lindau disease in the United States were attributed to retinal hemangioblastomas, making up approximately ~21% of the cases.
• The leading Von Hippel-Lindau (VHL) Disease Companies such as Roche, Exelixis, Bayer, Novartis, and others.
• Promising Von Hippel-Lindau (VHL) Disease Therapies such as Belzutifan, and others.
Delve deep into the Von Hippel-Lindau (VHL) Disease Market Landscape: Analyze drug adoption, treatment paradigms, and epidemiological shifts in our detailed Von Hippel-Lindau (VHL) Disease Market Forecast. Click here to shape the future @ Von Hippel-Lindau Disease Epidemiology Insights- https://www.delveinsight.com/sample-request/von-hippel-lindau-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Von Hippel-Lindau (VHL) Disease Overview
Von Hippel-Lindau (VHL) disease is a rare, inherited genetic disorder characterized by the formation of tumors and cysts in multiple organs. These tumors can be benign (non-cancerous) or malignant (cancerous). The disease is caused by mutations in the VHL gene, which plays a crucial role in regulating cell growth and blood vessel development.
Von Hippel-Lindau (VHL) Disease Epidemiology Insights
• Total Prevalent cases of Von Hippel-Lindau disease
• Total Diagnosed cases
• Clinical Manifestation-specific cases
• total treated cases
Navigate the complexities of the Von Hippel-Lindau (VHL) Disease Market: Gain insights into drug trends, treatment scenarios, and epidemiological data through our insightful Von Hippel-Lindau (VHL) Disease Market Forecast. Click here to get more insights @ Von Hippel-Lindau Disease Treatment Market- https://www.delveinsight.com/sample-request/von-hippel-lindau-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Von Hippel-Lindau Disease Marketed Drugs
• WELIREG (belzutifan): Merck
WELIREG (belzutifan), developed by Merck, received FDA approval in August 2021. It's indicated for adult Von Hipple-Lindau patients with renal cell carcinoma, CNS hemangioblastomas, or pancreatic neuroendocrine tumors not immediately needing surgery. Belzutifan inhibits HIF-2α, a key factor in oxygen sensing and gene regulation under hypoxia. By binding to HIF-2α, belzutifan disrupts its interaction with HIF-1β, reducing the expression of genes linked to proliferation, angiogenesis, and tumor growth. WELIREG approval was supported by LITESPARK-004 (NCT03401788), an open-label trial involving 61 Von Hipple-Lindau disease associated RCC patients with a documented Von Hipple-Lindau disease germline alteration and at least one measurable kidney tumor according to RECIST v1.1 criteria.
Emerging Von Hippel-Lindau Disease Drugs
• DFF332: Novartis
DFF332 is a small molecule being developed by Novartis as a single agent and in combination in patients with advanced clear cell renal cell carcinoma and other malignancies with HIF stabilizing mutations. The development in combination includes Everolimus (RAD001, an mTOR inhibitor), and also in combination with Spartalizumab (PDR001, an anti-PD1) plus Taminadenant (NIR178, an adenosine A2A receptor antagonist). DFF332 targets a protein called HIF2α; by acting on HIF2α, DFF332 may stop the growth of certain types of cancer. DFF332 is currently being evaluated in a clinical Phase I trial to treat advanced/relapsed ccRCC and other malignancies with HIF2α stabilizing mutations.
Unlock insights into the Von Hippel-Lindau (VHL) Disease Market: discover drug uptake patterns, treatment landscapes, and epidemiological insights with our exclusive Von Hippel-Lindau (VHL) Disease Market Forecast. Click here @ Von Hippel-Lindau (VHL) Disease Market Drivers and Barriers- https://www.delveinsight.com/sample-request/von-hippel-lindau-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Von Hippel-Lindau (VHL) Disease Drug Market
The existing Von Hippel-Lindau Disease treatment is mainly dominated by Hypoxia-inducible factor-2α (HIF-2α) inhibitor. Belzutifan is an inhibitor of hypoxia-inducible factor 2 alpha (HIF-2α). HIF-2α is a transcription factor that plays a role in oxygen sensing by regulating genes that promote adaptation to hypoxia. Under normal oxygen levels, HIF-2α is targeted for ubiquitin-proteasomal degradation by Von Hipple-Lindau disease protein. Lack of functional Von Hipple-Lindau disease protein results in stabilization and accumulation of HIF-2α. Upon stabilization, HIF-2α translocates into the nucleus and interacts with hypoxia-inducible factor 1 beta (HIF-1) to form a transcriptional complex that induces expression of downstream genes, including genes associated with cellular proliferation, angiogenesis, and tumor growth. Belzutifan binds to HIF-2α, and in conditions of hypoxia or impairment of Von Hipple-Lindau disease protein function, belzutifan blocks the HIF-2α-HIF-1 interaction, leading to reduced transcription and expression of HIF-2α target genes.
Von Hippel-Lindau Disease Market Outlook
For patients who have Von Hippel-Lindau disease, the goal of treatment is cancer control, not to cure cancer, and preservation of functional parenchyma to avoid the morbidity associated with renal or adrenal loss. Primary treatment of all Von Hippel-Lindau disease related tumors is local (i.e., surgical resection, RFA, radiotherapy). However, repeated local interventions at multiple sites or repeated recurrences in one area can increase morbidity. Therefore, in individual patients, systemic treatment may be an option.
Scope of the Von Hippel-Lindau (VHL) Disease Market Report
• Coverage- 7MM
• Von Hippel-Lindau (VHL) Disease Companies- Roche, Exelixis, Bayer, Novartis, and others.
• Von Hippel-Lindau (VHL) Disease Therapies- Belzutifan, and others.
• Von Hippel-Lindau (VHL) Disease Market Dynamics: Von Hippel-Lindau (VHL) Disease Market drivers and Von Hippel-Lindau (VHL) Disease Market Barriers
• Von Hippel-Lindau (VHL) Disease Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Von Hippel-Lindau (VHL) Disease Unmet Needs, KOL's views, Analyst's views, Von Hippel-Lindau (VHL) Disease Market Access and Reimbursement
Gain a strategic edge in the Von Hippel-Lindau (VHL) Disease Market: explore comprehensive drug insights, treatment updates, and epidemiological forecasts in our in-depth Von Hippel-Lindau (VHL) Disease Market Forecast. Click here to lead in advancements @ Von Hippel-Lindau (VHL) Disease Clinical Trials Assessment- https://www.delveinsight.com/sample-request/von-hippel-lindau-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1 Key Insights
2 Report Introduction
3 Executive Summary
4 Key Events
5 Epidemiology and Market Forecast Methodology
6 Von Hippel-Lindau disease Market Overview at a Glance
7 Disease Background and Overview
8 Treatment and Management
9 Epidemiology and Patient Population
10 Patient Journey
11 Marketed Therapies
12 Emerging Therapies
13 Von Hippel-Lindau Disease: 7 Major Market Analysis
14 Unmet Needs
15 SWOT Analysis
16 KOL Views
17 Market Access and Reimbursement
18 Appendix
19 DelveInsight Capabilities
20 Disclaimer
21 About DelveInsight
List of Top Selling Market Research Reports in 2024
Surgical Energy Generators Market- https://www.delveinsight.com/report-store/surgical-energy-generators-market
Surgical Sealant Tissue Patch Market- https://www.delveinsight.com/report-store/surgical-sealant-tissue-patch-market
Surgical Stapling Devices Market- https://www.delveinsight.com/report-store/surgical-stapling-devices-market
Vital Sign Monitoring Devices Market- https://www.delveinsight.com/report-store/vital-sign-monitors-external-remote-patient-monitoring-devices-market
Syphilis Market- https://www.delveinsight.com/report-store/syphilis-market
Vitreoretinal Surgery Devices Market- https://www.delveinsight.com/report-store/vitreoretinal-surgery-devices-market
Pelvic Organ Prolapse Market- https://www.delveinsight.com/report-store/pelvic-organ-prolapse-market
Scoliosis Market- https://www.delveinsight.com/report-store/scoliosis-market
SGLT2 Inhibitors Market- https://www.delveinsight.com/report-store/sglt2-inhibitors-market
Urinary Catheters Market- https://www.delveinsight.com/report-store/urinary-catheters-market
Carcinoid Syndrome Market- https://www.delveinsight.com/report-store/carcinoid-syndrome-market
Cardiac Monitoring Devices Market- https://www.delveinsight.com/report-store/cardiac-monitoring-devices-market
Varicose Vein Treatment Devices Market- https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market
Bone Growth Stimulators Market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Skin Neoplasms Market- https://www.delveinsight.com/report-store/skin-neoplasms-market
Thrombectomy Devices Market- https://www.delveinsight.com/report-store/thrombectomy-devices-market
Novel Drug Delivery Devices Market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
Lymphedema Market- https://www.delveinsight.com/report-store/lymphedema-market
Artificial Disc Market- https://www.delveinsight.com/report-store/artificial-disc-market
Exocrine Pancreatic Insufficiency Market- https://www.delveinsight.com/report-store/exocrine-pancreatic-insufficiency-epi-market
Fabry Disease Market- https://www.delveinsight.com/report-store/fabry-disease-market
Overactive Bladder Market- https://www.delveinsight.com/report-store/overactive-bladder-oab-market
Total Knee Arthroplasty Market- https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
Hip Replacement Devices Market- https://www.delveinsight.com/report-store/hip-reconstruction-devices-market
Lactose Intolerance Market- https://www.delveinsight.com/report-store/lactose-intolerance-market
HDAC Inhibitors Market- https://www.delveinsight.com/report-store/hdac-inhibitors-market
Ventral Hernia Market- https://www.delveinsight.com/report-store/ventral-hernia-market
Facial Lines Market- https://www.delveinsight.com/report-store/facial-lines-market
Medical Marijuana Market- https://www.delveinsight.com/report-store/medical-marijuana-market-insight
Microscopy Device Market- https://www.delveinsight.com/report-store/microscopy-device-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Yash Bhardwaj
info@delveinsight.com
+91-9650213330
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Von Hippel-Lindau Disease Treatment Market Size 2034 | Roche, Exelixis, Bayer, Novartis, and others. here
News-ID: 3643007 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Hip
Gospel Hip Hop and Christian Hip Hop has Its Hall of Fame: Emcee N.I.C.E. Induct …
Dr. Aulsondro "Novelist" Hamilton, professionally known as Emcee N.I.C.E., was honored with a prestigious induction into the Gospel Hip Hop and Christian Hip-Hop Hall of Fame during a remarkable ceremony held at the Black Wall Street Market in Atlanta, Georgia.
The establishment of a Gospel Hip Hop (GHH) and Christian Hip Hop (CHH) Hall of Fame was created to provide long-overdue recognition to artists who have made significant contributions to the…
Hip Replacement Market - Restoring Motion, Reclaiming Life: Hip Replacement for …
Newark, New Castle, USA: The "Hip Replacement Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Hip Replacement Market: https://www.growthplusreports.com/report/hip-replacement-market/7789
This latest report researches the industry structure, sales, revenue,…
Have Hip Pain? See The Total Hip Replacement Guide
Regardless of whether you have just started started investigating treatment choices or have effectively chosen to a hip replacement medical procedure, we hope this data will enable you to comprehend the advantages and disadvantages of total hip replacement surgery. This article depicts how typical hip functions, the reasons for hip pain, what’s in store from with a THR (Total Hip Replacement), and what activities and exercises will help reestablish your…
HIP Replacement Devices Market Report 2018: Segmentation by Product (Product (Pr …
Global HIP Replacement Devices market research report provides company profile for Zimmer Inc. (U.S.), DePuy Synthes (U.S.), Stryker (U.K.), Smith & Nephew (U.K.), B. Braun Melsungen AG (Germany), Corin (U.K.), and Waldemar LINK GmbH & Co. KG (Germany) and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume,…
Hip Replacement Implant Market: Rising Incidence of Hip Bone Disorders Fuels Gro …
The top three players in the global hip replacement market, collectively, contributed 74.7% of the overall revenue generation of the market in 2015, indicating towards consolidated nature of this arena. These players are Johnson & Johnson, Zimmer Biomet Holdings Inc., and Stryker Corporation. Transparency Market Research (TMR) observes that strong portfolio, high geographic outreach, and strong brand recognition are some of the factors contributing to the dominance of these companies.…
Bernstein Liebhard LLP Applauds FDA’s Request that Hip Manufacturers Produce D …
Bernstein Liebhard LLP Applauds FDA’s Request that Hip Manufacturers Produce Data on Metal Poisoning and Hip Implants
New York 5/12/2011 04:40 PM GMT (TransWorldNews)
On May 6, 2011, the U.S Food and Drug Administration (“FDA”) ordered 21 medical device manufacturers, including Johnson & Johnson, Zimmer and Stryker, to conduct post-market analysis to determine whether their metal-on-metal hip replacement implants put patients at an increased risk for chromium and cobalt poisoning. …
